Our News on Newswise

Male bladder cancer vulnerability could lead to a new treatment approach

UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein specific to men - may destroy cancer cells. Focusing on this male protein variant common in malignant bladder tumor cells may serve as a new...
28-Apr-2021 1:35 PM EDT Add to Favorites

Newswise: neuronTian.jpeg

PsychLight Sensor to Enable Discovery of New Psychiatric Drugs

UC Davis researchers develop PsychLight, a sensor that could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse.
28-Apr-2021 12:35 PM EDT Add to Favorites

New rapid COVID-19 test the result of university-industry partnership

A partnership between UC Davis and Maurice J. Gallagher, Jr., chairman and CEO of Allegiant Travel Company, has led to a 20-minute COVID-19 test. The method pairs a mass spectrometer with a powerful machine-learning platform to detect SARS-CoV-2 in...
26-Apr-2021 3:25 PM EDT Add to Favorites

Is raising the sales age of tobacco reducing youth smoking?

A new study, conducted by three UC Davis Comprehensive Cancer Center researchers, studies young adult smoking trends three years after the start of California’s law raising the sales age of tobacco to 21.
23-Apr-2021 2:05 PM EDT Add to Favorites

Catching more breast cancers when mammograms are limited

In one of the largest research projects of its kind, a new study published in JAMA Network Open looks at nearly 900,000 individuals and close to 2 million mammograms to come up with a new way to detect the most breast cancer cases with the fewest...
25-Mar-2021 5:45 PM EDT Add to Favorites

Study finds adolescents with autism may engage neural control systems differently

UC Davis Health researchers studying executive control in adolescents and young adults with autism have published new research that suggests a unique approach, rather than impairment.
12-Mar-2021 12:20 PM EST Add to Favorites

Fragile X premutation registry launches internationally

The UC Davis MIND Institute and the National Fragile X Foundation have launched an international registry of people carrying the fragile X premutation. The goal is to facilitate and encourage research about the genetic condition to improve...
3-Feb-2021 3:50 PM EST Add to Favorites

Biomarkers in mother’s plasma could aid in early autism diagnosis and intervention

UC Davis MIND Institute researchers used machine learning to crunch 10,000 autoantibody pattern combinations to identify maternal biomarkers associated with a sub-type of autism. The findings have implications for early diagnosis and intervention.
25-Jan-2021 12:50 PM EST Add to Favorites


See All News

Our Experts on Newswise

UC Davis Health experts available for interviews in English and Spanish on contact tracing

2-Oct-2020 2:55 PM EDT

Newswise: blumberg.jpg

UC Davis Infectious Disease Expert Available to Comment on COVID-19 following President’s Diagnosis

2-Oct-2020 12:35 PM EDT

UC Davis Health expert available to discuss pancreatic cancer: Why it is so lethal, and why there is hope

20-Jul-2020 2:05 PM EDT

Newswise: michaelmoore.jpg

The Surge in Throat Cancer, Especially in Men

Humanpapilloma virus (HPV) is now the leading cause of certain types of throat cancer. Dr. Michael Moore, director of head and neck surgery at UC Davis and an HPV-related cancer expert, answers some tough questions about the trend and what can be...
31-Jul-2018 6:05 PM EDT

Newswise: lenaertsmarc.jpg

Oh, My Aching Head! the Who, What, Why and How to Cope with Migraine

Migraine headaches can strike any time and be debilitating, making it impossible to work or enjoy even life’s simple pleasures. They affect approximately 12 percent of the population living in the U.S. and are three times more prevalent in women...
27-Jun-2018 1:05 PM EDT

Newswise: Murphy-17.jpg

UC Davis Researcher Urges Caution on Engineered Stem Cells

In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell...
3-Jan-2018 5:05 PM EST

Newswise: j_schweitzer.jpg

All the Rage, but Do They Work? UC Davis #ADHD Expert Offers Thoughts on #Fidget Toys

10-May-2017 3:05 PM EDT

Newswise: Abbeduto_2.jpg

#Autism, #vaccine experts can comment on Trump's Vaccine Safety Commission and Robert Kennedy Jr. leadership appointment

10-Jan-2017 4:05 PM EST

See All Experts

Our YouTube Videos

About

UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 15,000 adults and children every year and access to more than 150 active clinical trials at any given time. Its innovative research program engages more than 225 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Office of Community Outreach and Engagement addresses disparities in cancer outcomes across diverse populations, and the cancer center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists.

Contacts

Andon Carling
Web Communications

aacarling@ucdavis.edu

916-734-9430

Charles Casey
Public Information Officer
UC Davis Cancer Center

cecasey@ucdavis.edu

916-734-9048

Karen Finney
Senior Public Information Representative

klfinney@ucdavis.edu

916-734-9064

Edwin Garcia
Public Information Officer

edmgarcia@ucdavis.edu

916-734-9323

Doreen Purvis
Administrative Assistant - Public Affairs and Marketing

dpurvis@ucdavis.edu

916-734-9450

Tricia Tomiyoshi
Senior Public Information Officer

ttomiyoshi@ucdavis.edu

916-734-9706

Stephanie Winn
Senior PIO
Comprehensive Cancer Ctr.

stawinn@ucdavis.edu

916 501-9864

Pamela Wu
Director, Communications and Media Relations

pcwu@ucdavis.edu

916-734-9040

Nadine Yehya
Science Writer

nyehya@ucdavis.edu

Twitter

close
0.30213